A phase II multi-cohort single-arm study of tiragolumab with atezolizumab plus bevacizumab in previously treated advanced non-squamous non–small-cell lung cancer.

MLA

Reuss, Joshua E., et al. “A Phase II Multi-Cohort Single-Arm Study of Tiragolumab with Atezolizumab plus Bevacizumab in Previously Treated Advanced Non-Squamous Non–small-Cell Lung Cancer.” Journal of Clinical Oncology, vol. 41, June 2023, p. TPS9152. EBSCOhost, https://doi.org/10.1200/JCO.2023.41.16_suppl.TPS9152.

APA

Reuss, J. E., Wonser, D., Smith, K. N., Ahn, J., Byers, S., Creswell, K., Kim, C., Thompson, J., Crawford, J., Cohen, E., Zeck, J., Gutierrez, M., & Liu, S. V. (2023). A phase II multi-cohort single-arm study of tiragolumab with atezolizumab plus bevacizumab in previously treated advanced non-squamous non–small-cell lung cancer. Journal of Clinical Oncology, 41, TPS9152. https://doi.org/10.1200/JCO.2023.41.16_suppl.TPS9152

Chicago

Reuss, Joshua E., Dann Wonser, Kellie Nicole Smith, Jaeil Ahn, Stephen Byers, Karen Creswell, Chul Kim, et al. 2023. “A Phase II Multi-Cohort Single-Arm Study of Tiragolumab with Atezolizumab plus Bevacizumab in Previously Treated Advanced Non-Squamous Non–small-Cell Lung Cancer.” Journal of Clinical Oncology 41 (June): TPS9152. doi:10.1200/JCO.2023.41.16_suppl.TPS9152.